PTC THERAPEUTICS, INC. — Director's Dealing 2018

Dec 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2018-12-14

Reporting Person: Reeve Emma (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-14	Stock Option (Right To Buy)	$33.63	A	14000	Acquired	2028-12-13	Common Stock (14000.0)	Direct
2018-12-14	Stock Option (Right To Buy)	$33.63	A	1167	Acquired	2028-12-13	Common Stock (1167.0)	Direct

Footnotes

F1: This option award vests in thirty-six approximately equal monthly installments, commencing on January 14, 2019 and continuing on each successive monthly anniversary of thereafter, ending on the third year anniversary of the grant date.